Kenneth Stokholm

Kenneth Stokholm serves as the President and CEO of Sever Pharma Solutions since June 2019, overseeing an international pharmaceutical CDMO group with operations in Sweden, The Netherlands, and the US. Previous roles include Chairman of the Board at Disphar International BV, board member at Nordic Drugs, and various senior executive positions at Nordic Pharma where responsibilities encompassed technical operations, strategic development, and corporate business development. Stokholm's extensive experience also includes leadership roles at QPharma AB and Xellia Pharmaceuticals, where expertise in supply chain, operations, and production management was demonstrated. Educational qualifications encompass an Executive MBA from HEC Paris, a Mini MBA from CBS Executive Fonden, and an M.Sc. in Biotechnology from DTU - Technical University of Denmark.